Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-02-14 1:30 pm Purchase | 2021-12-31 | 13G | MOLECULAR TEMPLATES INC MTEM | BIOTECHNOLOGY VALUE FUND L P | 225,307 6.000% | 41,232 (+22.40%) | Filing History |
| 2022-02-11 4:49 pm Purchase | 2021-12-31 | 13G | MOLECULAR TEMPLATES INC MTEM | BB BIOTECH AG | 719,467 19.200% | 83,292 (+13.09%) | Filing History |
| 2022-02-10 11:06 am Purchase | 2021-12-31 | 13G | MOLECULAR TEMPLATES INC MTEM | PICTET ASSET MANAGEMENT SA | 220,068 5.860% | 220,068 (New Position) | Filing History |
| 2022-02-04 4:12 pm Sale | 2021-12-31 | 13G | MOLECULAR TEMPLATES INC MTEM | BlackRock Inc. BLK | 190,060 5.100% | -15,187 (-7.40%) | Filing History |
| 2021-09-14 06:13 am Sale | 2021-08-24 | 13D | MOLECULAR TEMPLATES INC MTEM | TAKEDA PHARMACEUTICAL CO LTD TAK | 154,311 4.100% | -40,555 (-20.81%) | Filing History |